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Bacterial infection occur frequently in children.  In 2015 more than 900,000 children below 5 
years were killed due to respiratory tract infections (RTIs).  Early life onset and prolonged use 
of antibiotics in children can leads to health complications later in life. Antibiotics prescribing 
in young children is affected by many factors and identifying these factors can provide an 
opportunity to develop strategies for better prescribing. 
The Norwegian government plans to reduce consumption of antibiotics agents with 30% by 
2020 compared to the level in 2012. 
 
Purpose 
The purpose of this study was to identify groups of children based on the trajectories obtained 
by total number of prescriptions collected during first three years of life using GBTM. 
 
Material and methods 
Data on redeemed antibiotic prescriptions was obtained from NorPD for all children 0-3 years 
born in Norway from 2004 to 2017. Those without a personal identifier number and less than 
two prescriptions were excluded. Group-based trajectory modeling is used to identify clusters 
of children that are following similar trajectories of a single indicator of interest like gender or 
birth season.  
 
Results 
A total of 184012 children were included. Trajectory models with four groups was considered 
best fit for our study based on the criteria of model selection in GBTM. Group 1 had 1.8% of 
children from population of 184012, in that the proportion of children with antibiotic 
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prescription was approximately 48%, group 2 had 39.7% of children in this the proportion of 
children with the antibiotic prescription was around 17%, group 3 had highest number of 
children 57.8% in that the proportion of children with antibiotic prescription was around 19%, 
group 4 consisted of lowest number of children 0.73% in it the proportion of antibiotic 
prescription was 58%. The average number of prescription in groups (1, 2, 3, and 4) were 
9.97/child, 2.74/child, 2.70/child and 12.01/child respectively.   The trajectories obtained as per 
birth season showed that the first peak in group with highest proportion of antibiotic 
prescriptions (red color curve) occurs around the first winter experience of children. There was 
no association between birth seasons and proportion of children collecting antibiotic 
prescription as per the trajectories obtained for the complete database, based on the descriptive 
table shown in results section. The trajectories based on gender for male and female were 
identical, and even the group sizes were approximately same for both genders.  
 
Conclusions 
Our results do not suggest marked differences among children born in birth seasons and the 
association to the trajectories showing proportion of antibiotics prescription collected. There 
was considerable difference in the group sizes and proportion of children in the trajectories 
obtained for prescription based by birth season. However, winter was the duration when 






AIC Akaike information criterion 
AMR Antimicrobial resistance 
AOM Acute otitis media 
BIC Bayesian information criterion  
DDD Defined daily dose 
FHI Folkehelseinstituttet  
FOR Fear of recurrence 
GBTM Group based trajectory modelling 
GP General Practitioner 
NorPD Norwegian prescription database 
PCV Pneumococcal conjugate vaccine 
PDC Proportion of days covered 
RTI Respiratory tract infection 
UTI Urinary tract infection 






1.1 Antibiotics and Children 
 
The public health strain of infectious diseases in childhood is vast. Children younger in age 
have higher chances to pick up infections due to tender immune system, and narrower passages 
(in sinus, bronchi and ear) . The other factors for high rate of infection transmission in childhood 
are close physical contact, and minimal use of sneezing / coughing behavior. In Norway, the 
first line of healthcare services are provided by general practitioners (GPs) for all citizens (1). 
 
Worldwide RTIs from bacteria are major cause of mortality and morbidity. In 2015 more than 
900,000 children 5 years were killed due to pneumonia. These numbers accounted for 16% of 
all deaths in that age group. Consumption of antibiotics shows cyclic variations, and in the 
Northern hemisphere, the number of users is normally highest during the winter months (2). 
Airway infections is the most frequent indication for treatment, and the one-year periodic 
prevalence of use is highest among children 0-3 years (3).  
 
In children 20-50% of the antibiotic prescriptions are given to treat nonbacterial upper 
respiratory tract infections, for that antibiotics are mostly ineffective. A study from Denmark 
shows that exposure to antibiotics differs significantly between children born in different 
seasons and age at first use of antibiotics (4).  
 
Further, children cannot be treated as a single homogenous group. There are major differences 
among neonates, infants, children and adolescents in respect to pharmacodynamics and 
pharmacokinetics. The efficacy and safety of medicine in children is primarily derived from 




Approximately one-third of outpatient medication prescription provided to children are either 
off-label or unapproved by monitoring authorities. Children given untested medicine might 
experience harm. As per documented pediatric adverse conditions for drugs used off label 
comprised chloramphenicol induced gray baby syndrome and propofol sedation related with 
cardiac failure and deadly metabolic acidosis (6). 
 
The AMR and emergence of multi-resistant bacterial strains is of clinical concern with major 
implications to public health worldwide. Several studies have highlighted increase in antibiotic 
resistance by bacterial pathogens to cause infections globally (7). There are differences in 
antibiotic use across the world based on local medication practices, availability of antibiotics 
without prescription, and where regulations of antibiotic usages are limited. In some countries 
with few resources, the antibiotic consumption would be less due to the drug shortage (8).  
 
A study in UK in pediatric centers found that changes in antibiotic prescription are not solely 
dependent on patients related factors. Newly qualified GPs from UK prescribe antibiotics less 
often than older GPs, also GPs with higher workload prescribe more antibiotics. The prescribers 
are influenced by social norms. Children, aged persons, smokers, females and people with 
multiple comorbidities possess higher risk of complications due to infections and are prescribed 
antibiotics frequently (9).  
 
As per a German study delayed antibiotic prescription, particularly waiting and observing is a 
good way for avoiding antibiotics especially in acute otitis media AOM (age > 24 months) and 




1. Wait and observe. The child is observed carefully by parents, a medical checkup or telephonic 
consultation is required. If the child’s condition does not improve or worsens, then the 
antibiotics be prescribed after 48 hrs. 
 
2. Give a prescription that can only be redeemed if there is no improvement. However, there is 
a risk that parents may hoard the antibiotics, take it themselves or give it to their child without 
a further visit to the doctor (10). 
 
Interventions to improve prescribing of antibiotics aims for usage of narrower spectrum of 
antibiotics instead of broad spectrum antibiotics and decrease inappropriate antibiotics 
prescribing. Interventions can be directed at general public, patients, physicians or 




1.2 Epidemiology of RTIs and UTIs 
 
Respiratory tract infections include colds (rhino pharyngitis), (AOM), laryngitis, bronchitis and 
pneumonia. However, AOM and pneumonia could have bacterial etiology (12). AOM is a 
widely occurring disease in early infancy and childhood. Approximately 10% of children have 
an issue of AOM by 3 months and by age of 3 years around 50-85% of children experience one 
episode of AOM. The peak age-specific incidence occurs in 6-15 months of age.  Despite 
several clinical trials, there is no agreement for optimal therapy of AOM. The proportion of 
patients receiving antibiotics treatment for AOM vary from 56% in Netherland to 95% in USA, 
Australia and Canada. For many years delayed antibiotic strategy for AOM has been 
encouraged (13). 
 
A Norwegian study covering 24,888 consultations on 19,938 patients during December 2004 
to November 2005 examined data on RTIs in children 0-6 years. RTI was common among 2-3 
years children, and the majority of diagnosis were of AOM, cough and upper respiratory tract 
infection. Antibiotics were prescribed in 26.2 % of the consultations (14). RTIs are monitored 
through Sykdompulsen, a registry of infectious diseases it is updated monthly for the number of 
consultations with GPs and emergency services. Consultations show seasonal variation for 
RTIs. The number of consultations is lower during holidays and public holidays. This is 
particular around Christmas / New Year and Easter and during the summer holiday weeks (15).  
 
UTIs are common bacterial infections in children below 2 years. Well-treated UTIs have overall 
a good outcome. However, delayed treatment can lead to renal scarring (16). Cumulative 
incidence of UTIs in children before the age of two years is 2.1% for girls and 2.2% for boys. 




As per a study in USA the recurrence rate for UTI in girls is significant despite the absence or 
presence of a urinary tract abnormality. Recurrence rate for UTI in males is less frequent, it 
affects approximately one third of those with UTI (18). Oral antibiotic treatment is preferred as 





1.3 Antibiotics Prescriptions in Norwegian Children 
 
The Norwegian Prescription database (NorPD) has been available since 2004. As per an article 
published in 2019, there is 11% reduction in consumption of antibiotics measured as DDD 
compared to 2012 (20). Five of the 20 most commonly delivered drugs to the age group 0-17 
years were antibiotics (21). 
 
In Norway in 2017, there were about 800,000 consultations of children 0-5 years at GPs and in 
emergency departments. RTIs was diagnosed in 34% of these cases (22). Several studies 
confirm that the amount of antibiotics agents consumed is associated to the level of resistance 
of pathogenic bacteria (23-24). Although Norway has low levels of antimicrobial resistance 
(25), the government published a plan to reduce the consumption of antibiotics agents with 30% 
by 2020 compared to the level in 2012 (26). 
 
 Another prescription register study from Norway records the delivery of antibiotics in children 
< 18 years. The proportion of prescription for antibiotics in 2016 was highest in the age group 
< 3 years with 389/1 000, compared with 164/1 000 for children in the age group 6 - 11 years. 
In children < 3 years in 2016 there were 412 prescription/1 000 boys compared to 363 
prescriptions/1 000 girls. From year 2005 to 2016 the number of prescriptions decreased by 




There are other reasons for reducing the consumption of antibiotics agents. There are 
gastrointestinal side effects like diarrhea and change in microbiota. A study in Finland found 
that use of antibiotics agents among children, especially macrolides, was associated with 
reduced diversity in microbiota (28). Broad-spectrum antibiotics change the properties of the 
microbiota, which is assumed to be function in the monitoring of the immune system (29). 
 
The relationship of postnatal exposures to antibiotics in the first year of life with later 
development of allergic diseases in children have been reported in some studies from several  
countries .A recent study conducted in Japan, found that the antibiotic use in first two years of 
age was associated to dermatitis and rhinitis. The same study also highlighted that children who 
were given antibiotics early in life later had increased probability of asthma (30). 
 
A study found that usage of antibiotics may enhance the probability of asthma by decreasing 
the defensive effect of microbial exposure. However, the confirmation of a relation between 
usage of antibiotics in children and development of asthma has been inconsistent (31). A study 
comparing the microbial profile between individuals with and without obesity found a lower 
distinctiveness of microbes in individuals with obesity. The first year of life is crucial for the 
development of the microbiome since the infant gut advances from sterile environment to a firm 
environment similar to adult gastrointestinal tract. There is incomplete recovery of microbiota 
after antibiotic treatment. These disturbances may lead to weight gain in future.  There is small 
association between consumption of antibiotics in infancy (<24 months) and childhood 






Another recent study in Denmark identified the association between birth seasons and delivery 
of antibiotics agents to children during the first year of life. The birth seasons were mapped as 
winter (December–February), spring (March-May), summer (June-August) and autumn 
(September-November). The probability of a first prescription enhanced with age throughout 
infancy and changed by season (4).  
 
However, it is unknown whether arbitrary set dates is optimal when predicting time to first 
treatment or number of treatments during the first 3 years of life. Prescribing of antibiotics to 
children before the age of three is influenced by many factors. The mapping of these factors 
could be utilized to target interventions to reduce prescribing. 
 
The Norwegian antibiotic prescription pattern from 2004 would had been effected by measures 
and events that occurred during the course of time like PKV, and mycoplasma epidemics (33), 
and seasonal influenza due to bacterial secondary infection (34). There are events that would 
reduce prescribing like introduction of PKV vaccination program. PKV had been the part of 
childhood vaccination program since 2006 (35). 
 
 There had been regular amendments in national guidelines for antibiotic usage in primary 
health care (36-38). Children born from 01.07.06 received the vaccine as the usual standard 
program, and those born from 01.01.06 had the option to obtain vaccination (39). As per a 
Norwegian cohort study that included children born in 2001-2008, the incidence of AOM and 
lower respiratory tract infections among children 12-36 months of age irrespective of 
vaccination status decreased by 1.5-2.5% for children born in 2008 compared with children 





There have been three major mycoplasma epidemics in Norway during 2006, 2011-12 and 
2016-17. It is mapped through a voluntary cooperation between FHI and medical 
microbiological departments in Norway (33, 39). However, it should be noted that most often 
children 3-15 years are affected by mycoplasma pneumonia (33). In Norway seasonal flu 
normally occurs between weeks 40-20. FHI shows that children under the age of 12 might 
receive secondary or simultaneous infections with ear and pneumonia during this duration. In 
this scenario, a doctor might prescribe treatment with antibiotics (34). 
 
The guidelines for pediatric treatment with antibiotics agents were first published in 2000 (36), 
were revised in October 2008 (27), then in November 2012 (37) and later in 2014-2015 (41). 
The major difference between the editions in 2000 and 2008 is stricter regulation for treatment 
of respiratory infections, and less frequent prescription for amoxicillin both for respiratory and 





1.4 Method for investigating Antibiotics consumption pattern 
 
In this project we use group based trajectory modeling to demonstrate differences in collection 
of antibiotic prescriptions and continuity across children 0-3 years. The purpose of using GBTM 
in our analysis is to better understand the time-varying antibiotic prescription patterns and ease 
the interpretation of results to identify hidden groups in trajectories.  
 
Group based trajectory modelling (GBTM) had been applied in clinical and non-clinical 
settings, and was initially developed to study the developmental pattern of criminal behavior. 
GBTM is now used in biomedical research in varied segments as chronic kidney disease 
progression, obesity, pain, smoking, medication adoption and adherence, and concussion 
symptoms (42, 43). 
 
In GBTM the trajectories from each group follow a unique response pattern. Initially the GBTM 
was meant to examine patterns of change over several years. The underlying groups identified 
by GBTM are not to be considered unique from one another, rather as a statistical 
approximation. There would be members in population that would clearly belong to a particular 
group while others would be tougher to classify (43).  
 
The trajectories obtained should not be considered as exact trajectories that individuals follow 
during a study period. It should be used as tool for interpreting heterogeneity in a data set and 




There are several measures to understand medication pattern (45), like Percentage of Days 
Covered (PDC). When antibiotic prescription patterns are to be estimated GBTM are superior 
to PDC. PDC limit the long term medication use to a single scalar, but GBTM accounts for 
varying patterns (46). This reduction in PDC makes time oriented changes in antibiotics 
prescription delivery difficult to interpret.   
 
GBTM is based on statistical method called finite mixture modeling (47). This may enable us 
to characterize patterns of antibiotic prescription over time and identify the prescription 
collection differences based on e.g. gender and birth seasons. However, these procedures could 
even be applied in birth period and antimicrobial prescription for children. 
 
For example, one study using GBTM was done among women recently diagnosed with 
gynecological cancers and fear of recurrence (FOR). FOR includes different types of fears 
related to illness like that cancer will progress, recur or metastasize. Several papers suggest that 
around 17-72% of cancer patients reported higher levels of FOR. High level of FOR remains in 
subgroup of cancer survivors even years after treatment is completed. Longitudinal studies can 
be used to describe changes in FOR over a period.  
 
However, more can be learned by finding subgroup of women that follow similar pattern of 
change over period. Probably, women who begin with high FOR that decreases with time might 
differ in characteristics to women with initial low FOR and remain stable. These changes over 




Figure 1.1. Trajectories of global fear (Source: Manne, S.L., Myers‐Virtue, S., Kissane, D., Ozga, M.L., Kashy, 
D.A., Rubin, S.C., Rosenblum, N.G. and Heckman, C.J., 2017. Group‐based trajectory modeling of fear of 
disease recurrence among women recently diagnosed with gynecological cancers) 
 
The first subgroup low-stable comprised 25.5% had low global FOR at first assessment and 
remained low over time. The high-decreasing subgroup comprised 25.3% of the sample initially 
had high global FOR, but it decreased over time. The third subgroup high-stable was largest 
with 49.1% of the sample. The women in this subgroup maintained high global FOR throughout 
the time. Previous studies have suggested that woman with high-stable FOR are more prone to 
be diagnosed with metastatic cancer (48, 49).  
 
Another study based on GBTM assessed adherence to antihypertensive medicines in adults in 
a pharmacy setting. Adherence to medication is the extent to that a patient consumes the 
medication as prescribed. Non-adherence is around 34-50% for chronic illness (50). Proportion 
of Days Covered (PDC) is one way to measure adherence in clinical settings. However, this 
results in loss of information especially on the pattern of adherence.  
 
As per above study a patient who misses medication every alternate days would have similar 
PDC to patient who discontinues medication halfway in treatment. Patients that discontinue 
medication need different mediation compared to those that forget to take medication, each 
group needs to separate intervention strategy to ensure they abide to proper intake of 
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antihypertensive medication. GBTM was used to measure adherence to medication in this 
example of pharmacy dispensing records. GBTM identified groups of patients that followed 
similar pattern of pharmacy medication refill behavior in this example. 
 
 
Figure 1.2   Trajectory Group Models with 2-5 groups (Source: Dillon, P., Stewart, D., Smith, S.M., 
Gallagher, P. and Cousins, G., 2018. Group‐based trajectory models: assessing adherence to 
antihypertensive medication in older adults in a community pharmacy setting).  
 
In figure 1.2 four models illustrate 2-5 adherence trajectory groups. The X-axis reflects 30 day 
interval in follow-up duration. The Y-axis reflects the number of days covered with 
antihypertensive medication during 30 days period. Adherence of 905 patients is shown for 
duration of 12 months using GBTM. The increase in number of groups provided better 
statistical fit BIC and AIC. The three-group model was considered best fit in this example as it 






The three group model illustrates three distinct trajectories, each trajectory reflects a pattern 
of medication adherence during a period of 12 months. The three groups are very high level 
of adherence 52.2 %, consistent high level 40.9% and low level of adherence 6.5% (50). The 
purpose of GBTM is to not find true number of trajectory groups. However, to find the distinct 
features in data (51). After 7-8 months the number of days covered with antihypertensive 
drugs in low level of adherence group drops from around 23 days to 13 days per month.  
 
In GBTM the fundamental concept of interest is the distribution of outcomes conditional on 
age (or time); that is, the distribution of outcome trajectories denoted by P(Yi |Agei ),  where 
the random vector Yi represents child i’s longitudinal sequence of collection of antibiotics 
prescription and the vector Agei represents child i’s age in months when each of those 
measurement is recorded. The group-based trajectory model assumes that the population 
distribution of trajectories arises from a finite mixture of unknown order J. The likelihood for 
each child i, conditional on the number of groups J, may be written as below (52). 





πj is the probability of being in group j, and the conditional distribution of Yi given membership 
in j is represented by the unknown parameter vector βj that among other things determines the 
shape of the group-specific trajectory. The trajectory is modeled with up to a 5th order 
polynomial function of age (52). 
 
Therefore, in GBTM individuals that follow a similar longitudinal progression of outcomes are 
identified and grouped together. GBTM assumes there are unrecognized subpopulation or 
separate groups based on their trajectory over time. Statistically, GBTM involves the concurrent 
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estimation of different regression models, linking the information from all models to identify 
the maximum probability of belonging to a potential trajectory group for the same individual 
(53).  
 
Several factors need to be considered while analyzing studies that implemented GBTM. These 
are the duration of the study, the number of trajectory groups resulting from the analysis, the 
curves of trajectory groups identified and the drugs category studied. The number of trajectories 
in most of the studies are 4-6 adherence groups. However, a study by Lo-Ciganic et al., for 
hypoglycemic drugs classified adherence patients in patients using seven trajectory groups (54).  
 
On the other hand, Greenley et al., found only two adherence trajectories for patients on 
thiorpurine in Inflammatory Bowel Disease (55). The main goal of GBTM is to describe and 
summarize different patterns, to ease the complexity of the situation and better understand 
differences between individual or patients behavior. Therefore, a key point is that the individual 







The main objective of this study is to investigate whether it is possible to identify groups using 
GBTM based on the trajectories obtained for overall number of prescriptions in the first 3 year 
of life. 




Our hypothesis assumes that it is possible to identify groups using GBTM to identify trajectories 

















3. Material and Method 
 
3.1 Data Material 
 
Data on dispensation of systemic antibiotics during the period 2004-2017 for the 0-3 years age 
group is obtained from NorPD. NorPD contains information about the drug user, drug and 
prescriber. The database consists of retrospective longitudinal data and includes complete 
disclosure data for the study population. The complete description of NorPD is described 
elsewhere in Furu (57).  
 
3.2 Method  
3.2.1 Study Design 
 
Descriptive analysis is done in a cross-sectional perspective while regression analysis is done 
in a cohort perspective. 
 
3.2.2 Study Population 
 
We included any children who collected more than or equal to 2 and less than or equal to 20 
antibiotic prescriptions in first three years. The database is divided into two base groups. First 
group consist of data without a valid pseudo birth date, second group (database II) consist of 
data with a valid pseudo birth date. The following chart shows the second database group with 
inclusion and exclusion. In database II an exclusion has been made if there is no pseudo birth 
number, or lack of information about gender. Missing data are common in any study, especially 
if data is collected repeatedly over time. The collection of a complete dataset on individual is 
almost impossible. For example, in a cross-sectional survey the missing data is in form of 
individual non-response. Here the individual is not able or does not want to respond to a 
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particular question. Figure 3.1 shows the inclusion and exclusion of prescriptions that were not 
assigned any permanent ID, had less than 2 or more than 20 prescriptions, missing data. Then 
we combined all the prescriptions with their respective valid patient ID.  
 
  
Figure 3.1 Flowchart for the inclusion and exclusion in the period 2004-2017. 
 
3.2.3 Variables and definition 
Prescription Delivery Year and month 
It is used to calculate age and time to first delivery of antibiotics. 
 
Patient ID Number 
These allow to follow the individuals over time. In our study it would be used to calculate the 
number of prescriptions given to respective individual patient. Those children without pseudo 
birth ID number are given ID Key. It is not possible to use these random numbers to follow 






Pseudo Birth Date 
SPSS was used to generate pseudo birth date. The pseudo birth date was calculated as taking 
the 15th of every month as pseudo date for children born in that particular month. This gives the 
least margin of error. This is significant to calculate the approximate age and time to first 
prescription of antibiotics. In some cases where the date of birth is before 15th of that respective 
month and they have received antibiotics treatment in the same month before the date of 15th, 
that individual would have negative age. We did not include these children in our dataset. 
 
Prescriptions 
The number of prescriptions delivered is used as a measure of consumption. Children with 
similar ID numbers are summed up with their total prescriptions individually. Furthermore, we 
included children with more than or equal to two prescription and less than or equal to 20 
prescriptions till the age of three years.  
 
Birth Season 
The four birth seasons would be considered for our analysis, they have been coded as 1,2,3,4 
by using SPSS. 
 
Seasons Months SPSS Code 
Winter December-February 1 
Spring March-May 2 
Summer June-August 3 
Autumn September-November 4 
 
Table 3.  1 Birth Seasons with corresponding months and codes in SPSS. 
 
Children born in the spring (March-May) would experience winter months at 8-10 months of 
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age. As per the pseudo birth date Children born on 15 May would be 9 months old on 15 
February and children born on 15 April would be 8 months old on 15 December.   
 
3.2.4 Software Used 
 
The following software were used 
1. IBM SPSS for removing variables from NorPD that were not relevant(dispensing date, 
patient without ID number, prescriber's year of birth, prescriber's sex, prescriber's profession 
code, prescriber without ID number, patient's residential county number, dispensing number, 
number of packages, prescription pharmacy retail price, number of DDD, prescription category, 
prescription category number, drug article number, drug brand name, drug package size, drug 
strength, drug package unit, DDD value, DDD unit). We used SPSS for dataset  analysis, 
removing missing values, creating pseudo date of birth, calculating age. 
2. Microsoft Excel was used to calculate average antibiotics prescription in children. 
3. GBTM analysis are performed using Stata/MP 16.0 for Windows (StataCorp Revision 2019, 
College Station, Tx, USA) 
 
The GBTM program a well-established SAS-based procedure for estimating group-based 
trajectory model. GBTM provides a statistical method to identify groups of separate trajectories 
that are summarized by a finite set of different polynomial functions of age or months as per 
maximum likelihood estimation (58, 59). The shape of individual trajectory is dependent on the 
order of polynomial function used for modeling. The order of polynomial should be high to 
match the shape that might emerge from data. This is significant to analyze cyclical patterns 
(56). This thesis uses cyclical pattern for analyzing antibiotic prescription collection during the 




Installation of Traj can be done by using the following commands within Stata. An extra 
command, trajplot, supports plotting the results. 
. net from http://www.andrew.cmu.edu/user/bjones/traj  
. net install traj, replace 
 
The datasets including variables of interest were transposed from long format to wide format in 





traj [ if exp ] , var( varlist ) indep( varlist ) model( string ) order( numlist ) 
trajectory variables var (varlist) dependent variable, here are the prescriptions taken during 0-3 
years of age.  
Indep (varlist) independent variables, it is when the dependent variables measured.  
Order( numlist) polynomial type ( (0=intercept, 1=linear, 2=quadratic, 3=cubic ) 
 
3.2.6 Model Selection 
 
The software provides three alternative specifications of p(.): the censored normal distribution 
also known as the Tobit model, the zero-inflated Poisson distribution, and the binary logit 
distribution. 
 
The following commands fits our four-group model to the antibiotics collection data during a 
defined period and graphs the results.  
traj, var(p1-p36) indep(t1-t36) model(logit) order(3 3 3 3) 
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The trajectories were obtained from the following Syntax 
trajplot, xtitle(Scaled Age) ytitle(Prevalence) 
 
PROJ TRAJ assigns group membership to each child where the posterior probability in that 
group is the highest. Parameter estimates are based on maximum likelihood through the quasi-
Newton optimization procedures and standard errors are almost by a first order Taylor series 
expansion (42). Trajectory groups are group of children following almost similar pattern of 
collection of antibiotics prescription. They do not belong to a trajectory group but are assigned 
probability of group membership. The cohort follows a continuous distribution; it should not 
be regarded as concrete or real (45). For example, table 3.2 gives an example of model selection 
using BIC criterion, and estimated group proportions. The model with 4 groups can be assumed 
to be best fit model as it has low BIC value, all groups size are above  5%. 
 




Polynomial Order of 











1 -18,000 2 100 - - - - 
2 -16,788 2, 3 46 54 - - - 
3 -15,999 2, 1, 3 25 50 25 - - 
4 -15,600 2, 3, 0, 3 10 20 30 40 - 
5 -15,100 1, 3, 3, 3, 3 4.7 19.3 9.2 21.5 35.3 
Table 3.2 Estimated group proportions should exceed 5.0%. 3 The model with the highest (least negative) BIC 
value is preferred. Trajectory shapes: 0, constant; 1, linear; 2, quadratic; and 3, cubic. Abbreviation: BIC, Bayesian 
Information Criterion. 
 
Therefore, in this thesis membership probability is estimated for each child subject to every 
trajectory. For example, Child A has the membership probability of 72% to trajectory 1, 15% 
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to trajectory 2, 3% to trajectory 3 and 10% to trajectory 4 in our four group model. The child 
would be assigned to the trajectory for which child has the highest probability.  
 
The model fitting process of the GBTM is repetitious and demanded running the model several 
times, changing the number of groups and assigned order each time to generate the best fitting 
model for the data.  When building group-based models we did not have a prior knowledge on 
deciding number of groups on how prescription of antibiotics changed over time. The following 
steps were used to generate the best fitting model. 
 
1. Determining the maximum number of groups. 
2. Select the optimal order for each group and run models, starting with one group model until 
maximum number of assigned groups is determined in a stepwise manner. 
3. Finalize the model with the appropriate number of groups that best fits the data. 
 
In this thesis the maximum number of groups was limited to 4 for avoiding small size of 
trajectory groups and for easy understanding of trajectories. It would not be informative to make 
large number of trajectories with a small number of individuals in each group. Secondly, the 
shape of trajectory for each group over times was decided based on the correct order of each 
equation. As per suggestion by Nagin et al., each group should be assigned to a second order at 
the beginning of the analysis and then keep changing till it reaches an optimal order for the best 
model (45).  
 
The PROJ TRAJ function can model up to a fourth order polynomial. We started analysis with 
one group model with quadratic order. Then we ran another models by changing the group from 
quadratic to linear and cubic till we got significant parameters.  
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Four groups were preferred in the models. The reason for opting four groups is to find high 
users of antibiotics, low users and in between both the high users and low users of antibiotics. 
In our analysis GBTM allows for inclusion of time-varying (seasons, prescriptions) and time 
stable (sex) predictors simultaneously to enhance the distribution accuracy and adjust the shape 
of each trajectory group. 
 
The analysis was initially conducted on 10%, 50% and finally 100% of the population. The 
order were run as (1 1 1), (2 2 2), (3 3 3 3), (1 1 2 2) and other combinations of polynomial 
functions for the entire population, population in each birth season and population in each 
gender. Across all distributions, a polynomial function of age determines group membership 
probability and group shape. The polynomial function is not similar across all individuals. 
GBTM assumes that trajectory data can be summarized by a finite number of polynomial 
functions. The possibility exist for each trajectory group to be shown as linear, quadratic or 
cubic polynomial function. As the polynomial number goes up it adds greater complexity to 
group shape. The higher order polynomial function would enhance fit if they genuinely provide 
a better description of data than lower order polynomial. 
 
Goodness-of-fit was evaluated at each step using the Akaike information criterion (AIC) and 
Bayesian information criterion (BIC; smaller the values, better the model). Models that had 
values of AIC and BIC nearer to zero or were more negative compared to other polynomial 
models were selected. The significance of AIC and BIC models is explained in the background 
section. If a particular model has close to zero percentage of population in one of the group, 
then that model was abandoned. The group size lower than 5% were accepted in our analysis 
as the population size is big. Therefore, even below 1% of the group size had more than 1000 
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4.1 GBTM Trajectories for complete dataset with 184012 children. 
 
A total of 184012 children within age group 0-3 years were included. The table 4.1 shows the 
distribution of population in our database based on birth season and gender. The study had more 
males than female population.  
 
Birth season Number Percent 
Winter 45084 24.5 
Spring 51255 27.8 
Summer 48923 26.5 
Autumn 38750 21.0 
Sex Number Percent 
Male 101849 55.3 
Female 82163 44.6 
 
Table 4.1 Number of children born as per birth season and sex 
  
Four group trajectory model with order cubic (3 3 3 3) was selected as best model for our study. 
The conditions for selecting the best fitting model have been explained above. In this 4 group 
model, four distinct patterns of antibiotic prescription collection were observed during the 0-3 
year duration for children. The figure 4.1 shows the output from Stata of our analysis.  The table 
provides us with AIC, BIC values, and group size. 
 
In this 4-group model four distinct pattern of antibiotic prescription collection were apparent 
during the 36 months follow up. They would be very high level (red color curve), high level 





Figure 4.1 Output from Stata analysis showing BIC and AIC values. 
 
Trajectories in shown in figure 4.2 identified children in following four categories 
• The maximum antibiotics prescription collection based on group size of 0.7% of total 
population. Around 60% of children in this group collected the prescription at 10 months of age 
(red color curve). 
• In the group representing 1.8% of total population. Around 50% of children in this group 
collected the prescription at 22 months of age (blue color curve). 
• In the group representing 39.7% of total population. Around 18% of children in this 
group collected the prescription at 16 months of age (orange color curve). 
• In the group representing 57.8% of total population. Around 17% of children in this 
group collected the prescription at 24 months of age (green color curve). 
 
The Y-axis represents the proportion of that specific group that got the antibiotic prescription. 




Figure 4.2 Trajectory models using 4 groups. The monthly predicted probability of antibiotic prescription 
collection in each group is plotted with solid lines. The observed proportion of children in each group that are 
taking antibiotics is plotted with dots.  
 
 
Table: 4.1 Children Characteristic by Trajectory Using a 4-Group Model 
 
 
 Group 1 Group 2 Group 3 Group 4 Total 
Group Size 1.81% 39.66% 57.78% 0.73% 100% 
Female (%) 1227 (44.1%) 31628 (46.9%) 48895 (43.4%) 413 (35.5%) 82163 
Male (%) 1558 (55.9%) 35850 (53.1%) 63691 (56.6%) 750 (64.5%) 101849 
Number of 
Prescription 





9.97 2.74 2.70 12.01 2.88 
Number of 
Children 
2785 67478 112586 1163 184012 
Birth season      
Winter (%) 784 (28.2%) 19087 (28.3%) 24959 (22.2%) 254 (21.8%) 45084 
Spring (%) 879 (31.6%) 23419 (34.7%) 26694 (23.7%) 263 (22.6%) 51255 
Summer (%) 713 (25.6%) 16437 (24.4%) 31450 (27.9%) 323 (27.8%) 48923 
Autumn (%) 409 (14.7%) 8535 (12.6%) 29483 (26.2%) 323 (27.8%) 38750 
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As shown in Table 4.1 the average number of prescriptions in groups with highest and lowest 
number of children is around 4 folds.  Total number of prescriptions given to children in our 
dataset is 531596 with average being 2.88 per child. Group 2 and group 3 have highest number 
of children in them and both the groups have average prescription near around 2.7 per child. 
 
The peak for group 2 is highest around 22 months, here the maximum percentage of children 
are born in spring (34.7%). Therefore, the peaks comes around 22nd month after their birth in 
spring season, which would be winter season period. Similarly, the peak for group is highest 
around 15th month, here the maximum percentage of children are born in summer & autumn 
(27.9% & 26.2%). Therefore, the peaks comes around 17 months after their birth in summer 


















4.2 Antibiotics prescription collection trajectories as per birth season 
 
The following figure 4.3 compares proportion of antibiotics collected by children born in four 
birth seasons and their pattern of antibiotic using trajectory models based on (2 2 2 3) order. 
The model was selected based on its best fit as per criteria mentioned in method section. 
 
 
Figure 4.3 Trajectory models using 4 groups. The observed proportion of children in each group as per their birth 
season (autumn, spring, summer and winter) that collected antibiotics is plotted with dotted lines. Highest 
proportion (red color curve), high proportion (blue color curve), medium proportion (orange color curve) and low 
proportion (green color curve). 
 
The highest proportion of children taking prescription have group size from (0.8-4.1%) during 
the four seasons. Children born in autumn (September-November) would experience winter at 
(3rd-6th, 15th-18th, 27th-30th) month of age, children born in winter (December-February) would 
experience winter months at (9th-12th, 21st-24th, 33rd-36th) month of age born in the spring 
(March-May) would experience winter months at (8th -10th, 20th-22nd, 32nd-34th) of age, those 
born in summer (June-August) would experience winter at (6th-8th, 18th-20th, 30th-32nd) month 
of age  As per the pseudo birth date Children born on 15 May would be 9 months old on 15 




• As per trajectories in autumn, group 2 with 62.6% has highest number of children with 
antibiotics prescription after 15 months. Children in group 4 has highest percentage of 
prescriptions at 24th month.  
 
• For spring season the group 2 with 72.3% has highest number of children with 
antibiotics prescription at 10th, 20nd and 32nd   month.  Even, children in group 4 with maximum 
percentage of prescriptions the increase is seen during the 10th, 20nd and 32nd   month. This 
corresponds to the winter cycle experienced by children born in spring. 
 
• For summer season the group 1 with 53.8% has highest number of children with 
antibiotics prescription at 8h, 19th and 29th    month.  Even, children in group 4 with maximum 
percentage of prescriptions the increase is seen during the 10th, 20nd and 32nd   month. This 
corresponds to the winter cycle experienced by children born in summer. 
 
• Children born in winter have two major groups with population of 48.4% and 41.3% 
those in group 1 attain maximum antibiotic usage at 13th and 24th month from the month of 
birth. Whereas, group 4 in winters the highest percentage of children with prescriptions are in 
12th and 24th month. There are two peaks in the group 4 in winters unlike in other seasons. 
 
The following figure 4.4 shows the number of antibiotics prescription collected by age in 
months (0-35) as per birth season. The star indicates when the children born in that respective 




Figure 4.4 Number of antibiotics prescriptions collected based by age in month. 
Each birth season has a cyclical order for the collection of antibiotics prescription over three 
years. Children born in the autumn are among the youngest at risk, as they face winter at age of 
2-4 months.  This is shown as the small peak at the very beginning of Figure 4.4, the pattern 
repeats after approximately 12 months. The clear peak for high prescription collection is seen 















4.3 Antibiotics prescription collection trajectories as per sex 
 
The following figure 4.5 compares proportion of antibiotics prescription collected by girls and 
boys. The order was run as (2 2 2 3), the model was selected based on its best fit as per criteria 
mentioned in method section. We observe almost similar trajectories for both the genders. The 
male population (55%) is higher than female (45%) population in our dataset. The trajectories 




Figure 4.5 Trajectory models using 4 groups. The observed proportion of children in each group as per 


















In this thesis, we hypothesized that there should exist some association between trajectories 
obtained from GBTM for total number of prescriptions given in children 0-3 years in Norway. 
In this study, for children factors (birth season & sex), the probability of being in four groups 
with different rate of antibiotic prescription collection was obtained. Using GBTM, our second 
objective of how birth season give different trajectories was achieved. From GBTM, distinct 
pattern of prescription collection pattern were obtained. 
 
5.1 Antibiotic prescriptions for complete dataset with 184012 children. 
 
 
The results demonstrate that children have different groups that follow a pattern of collection 
of antibiotics prescription during the first three years of life. The analysis of dataset reveals that 
there are distinct groups with significant difference in the average number of prescriptions 
collected till the age of 3 years. Group 4 with highest proportion of antibiotics prescriptions has 
1163 children, though the group size in 0.7%. The proportion of children born in winter in group 
4 is lowest among all the groups. As for group 1 has second highest proportion of prescription 
collection and the average prescription collection is 9.97/child. The group 4 in figure 4.2 has 
the highest percentage of boys compared to other groups. The higher proportion of children 
born in winter along with higher proportion of male in same group could be considered as factor 
for higher prescription collection.  A  Danish study found that season of birth effected the 
overall risk of redeemed antibiotic prescriptions (4).  There are studies that identified that male 
gender is at more risk of AOM. A study in Taiwan showed that boys 0-2 years were associated 
with higher recurrent AOM (61). However, some studies have found that there is no gender 





The higher average number of prescriptions in group 4 and group 1 could be due to recurrent 
respiratory tract infection. As per a study conducted on 1089 children till the age of 2 years, the 
10% of children with highest number of annual respiratory illness had a median of 9.6 acute 
respiratory infections per year (63). Assuming no data error, it could be interesting to explore 
why there exist peaks with so high proportion of children taking antibiotics, which children in 
total made up of group 4 in figure 4.2. The group had similar percentage (27.8%) of children 
born in summer and autumn. As for group 1 the most number of children were born in winter 
(28.2%) and spring (31.6%). Therefore, the two groups (1 and 4) with highest average number 
of prescription have no similarity for children born in birth season that should had been same.  
 
A study from Norwegian neonatal medical register recorded early sepsis and exposure to 
antibiotics agents in the first week of life. The study was conducted from 1 January 2009 to 31 
December 2011. It was found that 10,175 (6%) of all preterm infants were hospitalized in the 
first week of life, among them 39% received intravenous antibiotic treatment (64). The 
consequence of this antibiotic treatment in hospital means there is group of children who 
already had high dose of antibiotics in hospital and are probably collecting prescription as a 
follow up to their treatment. These group of children should be identified as they would have 
significant impact on average prescriptions as they are regular users of antibiotics due to some 
illness or treatment. The group 4 with average prescription of 12/child could be having children 
that were earlier admitted to hospital for treatment. 
 
5.2 Antibiotic prescriptions as per birth season 
 
 
Our finding show that compared to other seasons, children born in spring have highest group 
size among those who have collected prescriptions on antibiotics. The group with highest 
proportion of antibiotic prescriptions had their first peak while they experienced the first winter 
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season. For children born in autumn the peak in group 3 was after 5-6 months, those born in 
spring the peak was around 10 months, born in summer the peak was after 8 months and born 
in winter the peak was after 12 months. This can be linked to study conducted in 5 European 
countries that showed that increased intake of antibiotics in higher during winter months is due 
to prescription of antibiotics for treatment of viral infections.  (65). It suggests that antibiotics 
are still used improperly for diseases that are caused by viruses.  
 
5.3 Antibiotic prescriptions as per sex 
 
 
There are no distinct trajectories pattern among male and female children in our GBTM. A 
retrospective cohort study in Italy showed that there is modest gender difference for children 
under the age 24 months for usage of respiratory tract drugs (5). There has been a study that 
showed lower frequency of antibiotics treatment in girls than boys could be attributed to social 
factors. The study was conducted in South Asian countries (8). The same could not be said 
about Norway as there is more even distribution of socioeconomic structure. This could be one 
of the factor we observe similar trajectories for boys and girls. 
 
The GBTM is based on the idea that individual following the same developmental course may 
have peculiar characteristics which differ from other groups and they may follow different 
developmental courses during time. 
 
5.4 Strength of study 
 
The strength of our study is the complete data set with a personal identifier. The use of GBTM 
helped to show the patterns in different trajectories and what characteristic mattered in 
distinguishing differences among children in different groups in regards proportion of 
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antibiotics prescription collection. The data into trajectory groups, GBTM methodology to 
study the antibiotic prescription pattern in children provides a strong statistical tool to 
summarize large data in an easily understandable model. It is assumed that GBTM allows to 
discover hidden groups within the population that follow a different development trajectories. 
We opted months instead of 1 week as it would had generated ample signs on the group making 
it harder to interpret, 3 months interval would had made us loose the information. 
 
The other strength of GBTM for analyzing prescription pattern over time is that it is easily 
understandable graphically and it provides easy and provides tabular data summaries. This 
method takes into account the covariates, missing outcome and patterns within the same model 
(66). GBTM has advantages over other models used to study longitudinal data. It assumes that 
subgroups are part of the population but each group follows independent development pathways 
(47). GBTM are significant for groups that display more variation in prescription collection 





NorPD captures the prescriptions to children in Norway but has less information about 
chronic disease in children. There can be differences in prescription pattern based on 
prescriber practice, geographical healthcare units, and expectations of parents of children 
(67). In the method, we describe how pseudo age is defined as date of prescription minus 
pseudo age of birth here we have margin of error of a maximum of 16 days.  
 
GBTM can group individuals with similar course pattern. This modelling technique does 
not considers within-group variability, the variability of individual trajectory in the same 
course pattern. This would give different results compared to growth mixture modelling 
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and growth curve modelling (56). GBTM depends substantially on the professional 
perception of the investigator. This is particularly regarding the number of trajectories and 
the type of change (linear, cubic etc.) to be defined. Therefore, it is important to evaluate 
the existing literature on the variable (antibiotic prescription for this study) to understand 
the pattern they currently follow. Further, there was no information regarding the quantity 
of antibiotics prescribed in the prescription. The packet size of antibiotics could be with 
10, 20, 30 or more doses.  Therefore, children that receive high number of doses to be taken 
for longer duration would have less prescriptions compared to those who receive less doses 
for similar illness, they would be required to collect new prescription for more doses. To 
explain more about the antibiotic prescription collection several prescriber and patient 
variable could be included.   
 
We should also have information if the child had received any treatment in the hospital 
during newborn period. It could be that these children are high collectors of antibiotic 
prescription. It might be useful to be able to map children with high or low risk of asthma 
or other chronic diseases that might affect use of antibiotics before prescribing antibiotics. 
The prescription registry data could have more information on confounding factors that 
might be relevant to antibiotic prescription. The confounding factors could be method of 
delivery (normal or caesarean), siblings, passive smoking, socio economic factors, pre-
pregnancy BMI. The anatomical therapeutic classification (ATC) codes could had been 
also taken into account as confounding factors. It may be argued that our description of 
antibiotic use applies to a setting that is somewhat unusual. 
 
NorPD captures all dispensation of antibiotics from pharmacies to individuals. Data is 
considered valid and electronic records of prescription is required by law (57). Register data is 
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not affected by information and recall bias due to self-reporting of the drug use. However, as 
per the Norwegian medicine act 17 doctors can be given permission by Ministry to deliver 
medicines and other nursing items for fees if access to a pharmacy is cumbersome. It happens 
only with patients being far from pharmacies (60).  
 
It constitutes a small proportion and would not affect our estimates. Children have high 
prevalence of antibiotic users, and it is important to map the effect or lack of effect of measures 
related to prescribing in this age group. The proportion of registration with pseudo national ID 
number was highest during the early study period of 2004 to 2007. The problem with NorPD 
data is that we cannot be really sure if the collection of antibiotics from pharmacy actually 
consumed by children at home. We cannot validate if the dispensed antibiotics are used 































In this thesis we used GBTM to address the prescription patterns of antibiotics among children.  
It does so by defining trajectory groups based on number of prescriptions and time from birth 
to collection of prescriptions. This method as per best of my knowledge has not been used for 
antibiotics prescription in children 0-3 year age in other studies. Also, further studies to qualify 
the way to use other variables and clarify the accuracy of the dataset and needed to determine 
how the children should be accurately grouped to test which factors are associated with specific 
groups. Our results do not suggest marked differences among children born in birth seasons and 
the association of to the trajectories showing proportion of antibiotics prescription collected. 
 
Future, research on trajectory modeling should focus on inclusion of other factors that might 
possibly be affecting the outcome. There could be differences in prescription pattern for 
children based on the geographical location in Norway. For example, a Norwegian study found 
that residents in municipality with high consultation rates received 42% more prescription for 
RTIs compared to area with low consultation rates. The study included all municipalities with 
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